Optical Control of Cardiac Rhythm by In Vivo Photoactivation of an ERG Channel Peptide Inhibitor.

Authors:
Montnach J; Millet H; Persello A; Meudal H; De Waard S and 11 more

Journal:
Circ Res

Publication Year: 2023

DOI:
10.1161/CIRCRESAHA.123.322880

PMCID:
PMC10467801

PMID:
37593901

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Circ Res

Abbreviation: Circ Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Directional Endothelial Communication by Polarized Extracellular Vesicle Release.
Raju S; Botts SR; Blaser MC and 16 more (2024) - Transparency Score: 4/6
Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.
Murugesan P; Zhang Y; Huang Y and 6 more (2024) - Transparency Score: 3/6
Sox9 Accelerates Vascular Aging by Regulating Extracellular Matrix Composition and Stiffness.
Faleeva M; Ahmad S; Theofilatos K and 7 more (2024) - Transparency Score: 4/6
Cardiac Alternans: From Bedside to Bench and Back.
Qu Z; Weiss JN. (2023) - Transparency Score: 3/6
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
Hutcheson JD; Goettsch C. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures M. De Waard is a founder and consultant for Smartox Biotechnology. The other authors report no conflicts."

Evidence found in paper:

"Sources of Funding The authors acknowledge support from the French Agence Nationale de la Recherche (M. De Waard and M.E. Mangoni), the Fondation Leducq (M. De Waard), the Transatlantic Network of Excellence (M.E. Mangoni), the Région Pays de la Loire (M. De Waard) and the European FEDER (M. De Waard)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025